会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 52. 发明授权
    • Color overlay of scanned and reference images for display
    • 扫描和参考图像的颜色叠加显示
    • US5095447A
    • 1992-03-10
    • US617446
    • 1990-11-21
    • William G. MannsAnthony B. Wood
    • William G. MannsAnthony B. Wood
    • G01R31/308H04N1/04
    • G01R31/308H04N1/04H04N2201/0426Y10S715/965
    • A laser pattern inspection and/or writing system which writes or inspects a pattern on a target on a stage, by raster scanning the target pixels. Inspection can also be done by substage illumination with non-laser light. A database, organized into frames and strips, represents an ideal pattern as one or more polygons. Each polygon's data description is contained within a single data frame. The database is transformed into a turnpoint polygon representation, then a left and right vector representation, then an addressed pixel representation, then a bit-mapped representation of the entire target. Most of the transformations are carried out in parallel pipelines. Guardbands around polygon sides are used for error filtering during inspection. Guardbands are polygons, and frames containing only guardband information are sent down dedicated pipelines. Error filtering also is done at the time of pixel comparisons of ideal with real patterns, and subsequently during defect area consolidation. Defect areas are viewed as color overlays of ideal and actual target areas, from data generated during real time. Defect areas can be de-zoomed to allow larger target areas to be viewed. An autofocus keeps the scanning laser beam in focus on the target. The inspection system is used to find fiducial marks to orient the target prior to raster scanning. IC bars are provided with alignment marks for locating each IC bar. Interferometers or glass scale encoders allow the stage position to be known.
    • 激光图案检查和/或写入系统,其通过光栅扫描目标像素来写入或检查在舞台上的目标上的图案。 检查也可以通过非激光的分层照明进行。 组织成框架和条带的数据库表示作为一个或多个多边形的理想模式。 每个多边形的数据描述都包含在单个数据帧中。 将数据库转换为转折点多边形表示,然后转换为左和右向量表示,然后转换为寻址像素表示,然后是整个目标的位映射表示。 大多数转换是在并行管道中进行的。 多边形周围的保护带用于检查过程中的错误过滤。 保卫带是多边形,仅包含保护带信息的帧被发送到专用管道。 在理想与实际图案的像素比较时,随后在缺陷区域合并期间,也进行误差滤波。 缺陷区域被视为理想和实际目标区域的颜色叠加,从实时生成的数据。 缺陷区域可以去放大,以允许查看较大的目标区域。 自动对焦将扫描激光束保持在目标上。 检查系统用于在光栅扫描之前找到基准标记来定向目标。 IC条具有用于定位每个IC条的对准标记。 干涉仪或玻璃刻度尺可以让舞台位置知道。
    • 54. 发明授权
    • Compositions and methods for enhancing physiological performance and recovery time
    • 用于增强生理性能和恢复时间的组合物和方法
    • US09198929B2
    • 2015-12-01
    • US13102930
    • 2011-05-06
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • A61K9/14A61K33/00A23L1/30A23L2/54A61K41/00
    • A61K33/00A23L2/54A23L33/10A23V2002/00A61K9/0053A61K9/08A61K33/14A61K41/0004A23V2200/25A23V2200/33A23V2250/126
    • Provided are methods for enhancing exercise (e.g., intense, eccentric, elevated temperature, repetitive, aerobic, and high altitude) performance, comprising administering electrokinetically-altered aqueous fluids comprising an ionic aqueous solution of stably configured charge-stabilized oxygen-containing nanostructures predominantly having an average diameter of less than 100 nanometers. In certain aspects, enhancing exercise performance comprises at least one of: reducing plasma inflammatory cytokines (e.g., IFN-alpha, ENA-78 and BDNF); ameliorating muscle/tendon damage or enhancing muscle/tendon recovery; reducing biomarkers of exercise-induced muscle injury (e.g., CK-, plasma myoglobin); ameliorating exercise induced tendinosis, tendonitis, tenosynovitis, avulsion, and tendon strain associated with chronic repetitive movement or enhancing recovering therefrom; increasing VO2 max; decreasing RPE; reducing blood lactate; preserving muscle contractile function (e.g., maximal force, joint ROM); reducing muscle soreness; ameliorating onset of fatigue in an exercising subject. Improved methods for producing electrokinetically altered aqueous fluids (including sports beverages) are also provided.
    • 提供了用于增强运动(例如,强烈,偏心,升高的温度,重复,有氧和高海拔)性能的方法,包括施用电动改变的含水流体,其包含稳定配置的电荷稳定的含氧纳米结构的离子水溶液,其主要具有 平均直径小于100纳米。 在某些方面,增强运动性能包括降低血浆炎性细胞因子(例如IFN-α,ENA-78和BDNF)中的至少一种; 改善肌肉/肌腱损伤或增强肌肉/肌腱恢复; 减少运动性肌肉损伤的生物标志物(例如,CK-,血浆肌红蛋白); 改善运动诱导的腱鞘炎,腱炎,腱鞘炎,撕脱和与慢性重复运动相关的肌腱菌株或增强其从其中的恢复; 增加VO2 max; 减少RPE; 减少血液乳酸盐 保持肌肉收缩功能(例如,最大力,关节ROM); 减轻肌肉酸痛; 改善运动受试者的疲劳发作。 还提供了用于生产电动改变的含水流体(包括运动饮料)的改进的方法。
    • 56. 发明授权
    • Mixing device
    • 混合装置
    • US08410182B2
    • 2013-04-02
    • US12433741
    • 2009-04-30
    • Anthony B. WoodGregory J. ArchambeauRichard L. Watson
    • Anthony B. WoodGregory J. ArchambeauRichard L. Watson
    • B01F3/04C02F1/46
    • B01F5/0665A23L2/54A61J3/00A61K9/08A61K9/10A61K33/00B01F3/04099B01F3/04531B01F3/0807B01F3/0853B01F7/008B01F7/00816C02F1/727C02F3/02C09K3/00C12M27/00Y02W10/15
    • Provided are electrokinetically-altered fluids (e.g., gas-enriched (e.g., oxygen-enriched) electrokinetic fluids) comprising an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. Further provided are the methods of making the electrokinetically-altered ionic aqueous fluid compositions. Particular aspects provide for regulating or modulating intracellular signal transduction associated by modulation of at least one of cellular membranes, membrane potential, membrane proteins such as membrane receptors, including but not limited to G-Protein Coupled Receptors (GPCR), and intercellular junctions (e.g., tight junctions, gap junctions, zona adherins and desmasomes). Other embodiments include particular methods of producing the electrokinetically-altered fluids. The electrokinetically-altered fluid compositions and methods of producing the fluid include electrokinetically-altered ionic aqueous fluids optionally in the form of solvated electrons stabilized with molecular oxygen.
    • 提供了电动改变的流体(例如,富含气体(例如富氧)电动流体),其包含电荷稳定的含氧纳米结构的离子水溶液,其量足以在与电池接触时提供调制 细胞膜电位和细胞膜电导率中的至少一种。 进一步提供制备电动改性的离子水性液体组合物的方法。 特定方面提供调节或调节与细胞膜,膜电位,膜蛋白如膜受体(包括但不限于G蛋白偶联受体(GPCR))和细胞间结合(例如,细胞间接合)中的至少一种调节相关的细胞内信号转导。 ,紧密连接处,间隙连接处,扎胶粘合剂和粘胶)。 其它实施方案包括产生电动改变的流体的特定方法。 电动改变的流体组合物和制备流体的方法包括任选地以分子氧稳定的溶剂化电子的形式的电动改变的离子水性流体。
    • 59. 发明申请
    • BACTERIOSTATIC OR BACTERIOCIDAL COMPOSITIONS AND METHODS
    • BACTERIOSTATIC或BACTERIOCIDAL组合物和方法
    • US20100310665A1
    • 2010-12-09
    • US12773743
    • 2010-05-04
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • Richard L. WatsonAnthony B. WoodGregory J. Archambeau
    • A61K9/14A61K38/02A61K31/431A61P31/04
    • A61K31/137A61K9/0019A61K9/0078A61K31/58A61K2300/00
    • Particular aspects provide compositions and methods for treating bacterial infection or at least one symptom related to bacterial infection in a subject in need thereof by administering a therapeutic composition comprising at least one electrokinetically-altered fluid (including gas-enriched electrokinetically altered fluids) which comprise an ionic aqueous solution of charge-stabilized oxygen-containing nanostructures in an amount sufficient to provide, upon contact with a cell, modulation of at least one of cellular membrane potential and cellular membrane conductivity. The electrokinetically-altered ionic fluid compositions are sufficient to provide for modulation of intracellular signal transduction, wherein treating bacterial infection or at least one symptom related to bacterial infection is thereby afforded. In particular embodiments, the fluids are gas-enriched fluids or therapeutic compositions and methods, and include oxygen-enriched ionic aqueous solutions optionally in combination with other therapeutic agents. Other embodiments include particular routes of administration or formulations for the gas-enriched therapeutic compositions.
    • 具体方面提供了用于治疗有需要的受试者的细菌感染或与细菌感染相关的至少一种症状的组合物和方法,其通过施用包含至少一种电动改变的流体(包括富含气体的电动改变的流体)的治疗组合物,其包含 电荷稳定的含氧纳米结构的离子水溶液的量足以在与细胞接触时提供细胞膜电位和细胞膜电导率中的至少一种的调节。 电动改变的离子液体组合物足以提供细胞内信号转导的调节,由此提供治疗细菌感染或至少一种与细菌感染相关的症状。 在具体实施方案中,流体是富含气体的流体或治疗组合物和方法,并且包括任选地与其它治疗剂组合的富氧离子水溶液。 其它实施方案包括用于富含气体的治疗组合物的特定给药途径或制剂。